Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | May 12, 2017 at 8:40 AM EDT

G1 Therapeutics Announces Potential Pricing for IPO

G1 Therapeutics expects to offer more than 6 million shares in the range of $15 to $17 apiece in an…

Trey Thoelcke | May 11, 2017 at 11:40 AM EDT

Why Big Pharma Is Not at Fault for Record Drug Spending

With prescription drug spending breaking new records almost every year now, people like to blame Big Pharma and use it…

Jon C. Ogg | May 11, 2017 at 11:00 AM EDT

Merck’s Accelerated Keytruda Lung Cancer Approval Creates 3 Moves

It is no secret that pharma and biotech shares have had to deal with at least some headwinds over the…

Chris Lange | May 11, 2017 at 10:30 AM EDT

Why Sangamo Therapeutics Is Surging

Sangamo Therapeutics saw its shares skyrocket early on Thursday after a critical business update.

Chris Lange | May 10, 2017 at 10:40 AM EDT

Major Biotech Short Interest Remains Mixed

The April 28 short interest data have been compared with the previous report, and moves in the selected biotech stocks…

Chris Lange | May 10, 2017 at 9:00 AM EDT

Short Interest in Major Pharma Shrinks

The April 28 short interest data have been compared with the previous figures, and short interest moves in these selected…

Lee Jackson | May 10, 2017 at 8:30 AM EDT

4 Biotech and Specialty Pharma Stocks With 80% to 200% Upside Potential

The analysts at Stifel have focused on biotech and specialty pharma companies that not only have data that could prove…

Chris Lange | May 9, 2017 at 12:05 PM EDT

Is Valeant for Real This Time?

With earnings this positive and shares responding as a result, investors have to wonder if Valeant Pharmaceuticals is for real…

Paul Ausick | May 9, 2017 at 7:45 AM EDT

How Valeant Earnings Beat Estimates

Canadian pharmaceutical maker Valeant posted a big beat on both earnings and revenues Tuesday morning. The company also raised its…

Chris Lange | May 8, 2017 at 1:40 PM EDT

MannKind Jumps After Amazon Prime Takes on One Drop

MannKind Corp. (NASDAQ: MNKD) saw its shares make a massive gain on Monday after it was announced that its One…

Chris Lange | May 8, 2017 at 11:33 AM EDT

Horizon Pharma Sinks on Missed Earnings and Guidance

Horizon Pharma PLC (NASDAQ: HZNP) saw its shares hit a 52-week low on Monday after the company released its first-quarter…

Chris Lange | May 6, 2017 at 9:10 AM EDT

Did Immunomedics Rise Too Much as Seattle Genetics Deal Terminated?

Immunomedics watched its shares make a massive gain on Friday after the company announced the termination of its licensing deal…

Chris Lange | May 5, 2017 at 11:05 AM EDT

AmpliPhi Biosciences Crumbles After Announcing Secondary Offering

AmpliPhi Biosciences saw its shares crater on Friday after the company announced that pricing of its secondary offering.

Lee Jackson | May 5, 2017 at 8:20 AM EDT

JPMorgan Has 3 Top Pick Large Cap Pharmaceuticals to Buy for the Rest of 2017

JPMorgan has made the case that the best place for investors to look when considering large cap drug stocks is…

Chris Lange | May 3, 2017 at 11:25 AM EDT

Pieris Pharma Soars on AstraZeneca Collaboration

Shares of Pieris Pharmaceuticals saw perhaps one of the biggest gains on Wednesday after the company announced a critical collaboration…

1 … 167 168 169 170 171 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

G1 Therapeutics Announces Potential Pricing for IPO

Why Big Pharma Is Not at Fault for Record Drug Spending

Merck’s Accelerated Keytruda Lung Cancer Approval Creates 3 Moves

Why Sangamo Therapeutics Is Surging

Major Biotech Short Interest Remains Mixed

Short Interest in Major Pharma Shrinks

4 Biotech and Specialty Pharma Stocks With 80% to 200% Upside Potential

Is Valeant for Real This Time?

How Valeant Earnings Beat Estimates

MannKind Jumps After Amazon Prime Takes on One Drop

Horizon Pharma Sinks on Missed Earnings and Guidance

Did Immunomedics Rise Too Much as Seattle Genetics Deal Terminated?

AmpliPhi Biosciences Crumbles After Announcing Secondary Offering

JPMorgan Has 3 Top Pick Large Cap Pharmaceuticals to Buy for the Rest of 2017

Pieris Pharma Soars on AstraZeneca Collaboration

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

Live: Lumentum Q3 Earnings Tonight. Can the 15x Surge Continue?

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

Google Moves to Sell TPUs Directly: A Major Shift That Might Pressure NVIDIA’s AI Compute Dominance

Bitcoin Breaks $80K but Ripple (XRP) Is Lagging Again: Why Isn’t Capital Rotation Happening?

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Seven Out of Every Ten Dollars of Americans $18.8 Trillion Debt Is Tied To A House

Live: Will BigBear Beat Earnings Tonight?

Live: Supermicro Reports Q3 Earnings Tonight. Can Strong Results Spark a Rebound?

Health and Healthcare Articles

All Health and Healthcare Articles

G1 Therapeutics Announces Potential Pricing for IPO

Why Big Pharma Is Not at Fault for Record Drug Spending

Merck’s Accelerated Keytruda Lung Cancer Approval Creates 3 Moves

Why Sangamo Therapeutics Is Surging

Major Biotech Short Interest Remains Mixed

Short Interest in Major Pharma Shrinks

4 Biotech and Specialty Pharma Stocks With 80% to 200% Upside Potential

Is Valeant for Real This Time?

How Valeant Earnings Beat Estimates

MannKind Jumps After Amazon Prime Takes on One Drop

Horizon Pharma Sinks on Missed Earnings and Guidance

Did Immunomedics Rise Too Much as Seattle Genetics Deal Terminated?

AmpliPhi Biosciences Crumbles After Announcing Secondary Offering

JPMorgan Has 3 Top Pick Large Cap Pharmaceuticals to Buy for the Rest of 2017

Pieris Pharma Soars on AstraZeneca Collaboration

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

Live: Lumentum Q3 Earnings Tonight. Can the 15x Surge Continue?

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

Google Moves to Sell TPUs Directly: A Major Shift That Might Pressure NVIDIA’s AI Compute Dominance

Bitcoin Breaks $80K but Ripple (XRP) Is Lagging Again: Why Isn’t Capital Rotation Happening?

Featured Reads

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Seven Out of Every Ten Dollars of Americans $18.8 Trillion Debt Is Tied To A House